We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Dedicated to our clients' success
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
8 August 2018
TransLink Capital, a leading US venture capital fund, has invested as lead investor in the Series A financing round of aktiia SA, Neuchâtel, a Swiss startup active in optical blood pressure monitoring. VISCHER advised TransLink Capital as Swiss counsel in this financing round. The VISCHER team included Christian Wyss (Partner, Corporate/M&A) and Gian-Andrea Caprez (Managing Associate, Corporate/M&A).
Categories: Life Sciences, Pharma, Biotech, Mergers & Acquisitions, Private Equity & Venture Capital, Startup Desk, Deals & Cases
Attorney at Law
Cisco (NASDAQ: CSCO) intends to acquire Isovalent, a leader in open source cloud native networking...
Funds advised by Bregal Unternehmerkapital acquire Netrics Group, one of the largest cloud and...
Caprez, Gian-Andrea / Wyss, Christian / Zumstein, Luzius / Bernet, Sandro, VENTURE CAPITAL...